1. Idiopathic pulmonary fibrosis: Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy;Watters, L.C.; Schwarz, M.I.; Cherniack, R.M.; Waldron, J.A.; Dunn, T.L.; Stanford, R.E.;Am Rev Respir Dis,1987
2. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis;Nagaoka, I.; Trapnell, B.C.; Crystal, R.G.;Clin Invest,1990
3. Platelet-derived growth factor in idiopathic pulmonary fibrosis;Antoniades, H.N.; Bravo, M.A.; Avila, R.E.; Galanopoulous, T.; Neville-Golden, J.; Maxwell, M.;Clin Invest,1990
4. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation byinterferon gamma;Shaw, R.J.; Benedict, S.H.; Clark, R.A.F.; TEJr, King;Am Rev RespirDis,1991
5. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis;Khalil, N.; O'Connor, R.N.; Unruh, H.W.; Warren, P.W.; Flanders, K.C.; Kemp, A.;Am Respir CeU Mol Biol,1991